GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

Bloomberg Published Updated Economy Read at the source
Sign in to save

AnalystMarkets analysis

Expected market reaction

Bearish Confidence 60% How confidence is read Horizon: Short term Impact: Low

Evidence trail

Evidence
Source Bloomberg
Claim GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs
AI inference Bearish · 60%
Generated 2026-05-18 20:18

AI provenance

Analysed by Rule-Based Analysis not AI Methodology v1.0 Generated
Technical identifiers
Provider tag
free-analysis-rule-based-analysis
Analysis version
free-analysis-rule-based-analysis
Article id
84925

Original source

Justin Schrieber, CEO of telehealth company LifeMD, said that the main reason that Americans end up at virtual health care providers is to access GLP-1 weight loss medication, as well as other prescription medication. Schreiber said that there is still an untapped market for GLP-1 access and the next frontier of virtual access is for hormone replacement care. (Source: Bloomberg)

Read the full article on Bloomberg

Original article published by Bloomberg on May 18, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Rule-Based Analysis · 45.9% correct across 848 scored calls on indices See the full record